Guardant Health director gets 1,651 vested shares

Guardant Health, Inc. (GH) reported that director Alex M. Azar II had 1,651 Restricted Stock Units convert into 1,651 shares of Common Stock on September 12, 2026, at a stated price of $0.00 per share, reflecting a vesting event rather than a market sale.

Rhea-AI Filing Summary

Guardant Health, Inc. (GH) reported that director Alex M. Azar II had 1,651 Restricted Stock Units convert into 1,651 shares of Common Stock on September 12, 2026, at a stated price of $0.00 per share, reflecting a vesting event rather than a market sale.

The Restricted Stock Unit award was granted on September 12, 2025 and vests over four years, with 25% of the shares vesting on September 12, 2026 and the remaining 75% vesting monthly over the following three years. After this vesting, 4,953 Restricted Stock Units and 1,651 Common Stock shares are held directly, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

1,651 shares exercised/converted

Exercise 2 txns

Insider Azar Alex M II

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F2	1,651	$0.00	$0.00
Exercise	Common Stock	1,651	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 4,953 contracts (Direct); Common Stock — 1,651 shares (Direct)

Footnotes (2)

1. F1. The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter.
2. F2. Not applicable for Restricted Stock Units.

Key Figures

RSUs Converted: 1,651 units Common Shares Acquired: 1,651 shares Conversion Price: $0.00 per share +5 more

8 metrics

RSUs Converted 1,651 units Restricted Stock Units converted into Common Stock on September 12, 2026

Common Shares Acquired 1,651 shares Common Stock received upon RSU vesting on September 12, 2026

Conversion Price $0.00 per share Stated price for RSU conversion into Common Stock

RSUs Held After Transaction 4,953 units Restricted Stock Units held directly after the September 12, 2026 vesting

Common Shares Held After Transaction 1,651 shares Common Stock held directly after the September 12, 2026 conversion

RSU Grant Date September 12, 2025 Date the Restricted Stock Unit award was granted

Initial Tranche Vested 25% of award Portion of RSU award vesting on September 12, 2026

Remaining Vesting Period 3 years Remaining 75% of RSU award vests monthly over three years after September 12, 2026

Key Terms

Restricted Stock Units, Common Stock, vested

3 terms

Restricted Stock Units financial

"The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Common Stock financial

"underlying_security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vested financial

"25% of the shares subject to such award vested on September 12, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity transaction did GH report for director Alex M. Azar II?

Alex M. Azar II reported the conversion of 1,651 Restricted Stock Units into 1,651 shares of Common Stock on September 12, 2026, at a stated price of $0.00 per share, reflecting a vesting event rather than an open-market trade.

How many Guardant Health (GH) Restricted Stock Units vested on September 12, 2026?

On September 12, 2026, 1,651 Restricted Stock Units vested and were converted into an equal number of Common Stock shares for director Alex M. Azar II as part of a previously granted equity award.

What is the vesting schedule of the Guardant Health (GH) RSU award reported?

The Restricted Stock Unit award was granted on September 12, 2025. 25% of the shares vested on September 12, 2026, and the remaining 75% is scheduled to vest monthly over the following three-year period.

How many Guardant Health (GH) RSUs and shares does the director hold after this transaction?

Following the reported vesting, Alex M. Azar II holds 4,953 Restricted Stock Units directly and 1,651 shares of Common Stock directly, as stated in the filing’s post-transaction holdings data.

Was a Rule 10b5-1 trading plan used for this GH insider transaction?

No. The filing indicates that no Rule 10b5-1 trading plan was reported for these transactions; they reflect scheduled vesting of an existing Restricted Stock Unit award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 06:12 PM Accepted by SEC EDGAR 09/14/2026 - 06:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Azar Alex M II

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2026		M		1,651	A	$0	1,651	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	09/12/2026		M			1,651	(1)	(2)	Common Stock	1,651	$0	4,953	D

Explanation of Responses:

1. The restricted stock unit award was granted on September 12, 2025 and vests over a four-year period. 25% of the shares subject to such award vested on September 12, 2026 and the remaining 75% vests monthly for the three-year period thereafter.

2. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Alex M. Azar II	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)